Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices – ET HealthWorld
London: medical technology company Zimmer Biomet Holdings beat Wall Street estimates by first quarter profit on Thursday, on the back of robust demand for its devices that are used on the knee and hip reconstruction procedures. Zimmer results extend a good quarter for medical device manufacturersincluding rival Stryker Corp, which raised its annual profit outlook … Read more